Henry Meds vs MangoRx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Henry Meds
Best for mainstream telehealth GLP-1 accessStarting at $249/mo
MangoRx
Best for pending product verificationStarting at $199/mo
Side-by-Side Comparison
| Feature | Henry Meds | MangoRx |
|---|---|---|
| Overall Score | ✓7.2/10 | 7.1/10 |
| Starting Price | $249/mo | ✓$199/mo |
| Editorial Rating | 3.6 ★ /5 | 3.6 ★ /5 |
| Features | ✓4 features | 3 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Henry Meds
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
MangoRx
Pros
- ✓Katalys-approved program at 14% commission — attractive on higher AOV orders
- ✓Men's-health-focused telehealth — bundled GLP-1 + TRT + ED + hair lets a single user fill multiple needs through one provider
Cons
- ✗Stub entry — exact GLP-1 drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
- ✗Cross-selling TRT alongside GLP-1s is editorially worth disclosing — readers looking specifically for weight loss may not want to be funneled into a men's-hormone broader program
Our Verdict
Henry Meds edges out MangoRx with a higher overall score of 7.2/10 and is particularly strong for mainstream telehealth GLP-1 access. MangoRx remains a solid alternative, especially if you're looking for pending product verification.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.